[Toxoplasmosis in thromboangiitis obliterans].
D001688:Biological Products / Q000627:therapeutic use*; D002751:Chlortetracycline / Q000627:therapeutic use*; D006801:Humans; D013449:Sulfonamides / Q000627:therapeutic use*; D013919:Thromboangiitis Obliterans / Q000209:etiology*; D014123:Toxoplasmosis / Q000150:complications*
D001688:Biological Products; D013449:Sulfonamides; D002751:Chlortetracycline
BIOLOGICAL PRODUCTS/therapeutic use; CHLORTETRACYCLINE/therapeutic use; SULFONAMIDE MIXTURES/therapeutic use; THROMBOANGIITIS OBLITERANS/etiology and pathogenesis; TOXOPLASMOSIS/complications
Zur Frage der Toxoplasmose bei obliterierenden Angoorganopathien.